183 related articles for article (PubMed ID: 16133083)
21. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
[TBL] [Abstract][Full Text] [Related]
22. [The use of recombinant activated factor VII for blood loss after cardiovascular surgery].
Gong ZY; Gao CQ; Xiao CS; Li BJ; Ma XH; Zhang CM
Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(19):1497-501. PubMed ID: 19094631
[TBL] [Abstract][Full Text] [Related]
23. Recombinant factor VIIa as last-resort treatment of desperate haemorrhage.
Palmason R; Vidarsson B; Sigvaldason K; Ingimarsson JP; Gudbjartsson T; Sigurdsson GH; Onundarson PT
Acta Anaesthesiol Scand; 2012 May; 56(5):636-44. PubMed ID: 22489992
[TBL] [Abstract][Full Text] [Related]
24. Aprotinin in pediatric neuromuscular scoliosis surgery.
Kasimian S; Skaggs DL; Sankar WN; Farlo J; Goodarzi M; Tolo VT
Eur Spine J; 2008 Dec; 17(12):1671-5. PubMed ID: 18820953
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of recombinant activated factor VII in nonhemophilia children with severe or life-threatening bleeding: a report from the SeveNBleeP registry.
Blatný J; Mathew P; Monagle P; Ovesna P; Fiamoli V
Blood Coagul Fibrinolysis; 2014 Jun; 25(4):326-32. PubMed ID: 24389586
[TBL] [Abstract][Full Text] [Related]
26. Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa.
Bartal C; Freedman J; Bowman K; Cusimano M
J Trauma; 2007 Oct; 63(4):725-32. PubMed ID: 18089997
[TBL] [Abstract][Full Text] [Related]
27. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
[TBL] [Abstract][Full Text] [Related]
28. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.
Guzzetta NA; Huch S; Fernandez JD; Tosone SR; Miller BE
Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947
[TBL] [Abstract][Full Text] [Related]
29. Does the intraoperative tranexamic acid decrease operative blood loss during posterior spinal fusion for treatment of adolescent idiopathic scoliosis?
Yagi M; Hasegawa J; Nagoshi N; Iizuka S; Kaneko S; Fukuda K; Takemitsu M; Shioda M; Machida M
Spine (Phila Pa 1976); 2012 Oct; 37(21):E1336-42. PubMed ID: 22772572
[TBL] [Abstract][Full Text] [Related]
30. A double-blind, randomized, controlled study to explore the efficacy of rFVIIa on intraoperative blood loss and mortality in patients with severe acute pancreatitis.
Lu J; Liao LM; Geng YX; Wang X; Tong ZH; Ke L; Li WQ; Li N; Li JS
Thromb Res; 2014 Apr; 133(4):574-8. PubMed ID: 24457144
[TBL] [Abstract][Full Text] [Related]
31. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
[TBL] [Abstract][Full Text] [Related]
32. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
33. Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.
Valentino LA; Cooper DL; Goldstein B
Haemophilia; 2011 Jul; 17(4):579-89. PubMed ID: 21294815
[TBL] [Abstract][Full Text] [Related]
34. Off-label use of recombinant factor VIIa in two tertiary hospitals in Queensland.
Donovan PJ; Iedema J; McLeod DS; Kubler P; Pillans P
ANZ J Surg; 2013 Mar; 83(3):149-54. PubMed ID: 23137066
[TBL] [Abstract][Full Text] [Related]
35. Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.
Karsies TJ; Nicol KK; Galantowicz ME; Stephens JA; Kerlin BA
Ann Thorac Surg; 2010 Feb; 89(2):570-6. PubMed ID: 20103344
[TBL] [Abstract][Full Text] [Related]
36. Experience of recombinant activated factor VII usage during surgery in patients with haemophilia with inhibitors.
Polyanskaya T; Zorenko V; Karpov E; Sampiev M; Mishin G; Vasiliev D
Haemophilia; 2012 Nov; 18(6):997-1002. PubMed ID: 22672066
[TBL] [Abstract][Full Text] [Related]
37. Use of recombinant activated factor VII in severe post-partum haemorrhage: data from the Italian Registry: a multicentric observational retrospective study.
Barillari G; Frigo MG; Casarotto M; Farnia A; Massè B; Wetzl R; Bianchin A; Rabi A; Malacarne P; Pasca S; Bigotto E;
Thromb Res; 2009 Dec; 124(6):e41-7. PubMed ID: 19783283
[TBL] [Abstract][Full Text] [Related]
38. Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances.
Gkiougki E; Mitsiakos G; Chatziioannidis E; Papadakis E; Nikolaidis N
J Pediatr Hematol Oncol; 2013 Apr; 35(3):221-6. PubMed ID: 23511491
[TBL] [Abstract][Full Text] [Related]
39. Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations.
Andersen ND; Bhattacharya SD; Williams JB; Fosbol EL; Lockhart EL; Patel MB; Gaca JG; Welsby IJ; Hughes GC
Ann Thorac Surg; 2012 Jun; 93(6):1921-8; discussion 1928-9. PubMed ID: 22551846
[TBL] [Abstract][Full Text] [Related]
40. Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients.
Park P; Fewel ME; Garton HJ; Thompson BG; Hoff JT
Neurosurgery; 2003 Jul; 53(1):34-8; discussion 38-9. PubMed ID: 12823871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
